Summary of the payer’s published policy. Not a coverage determination — confirm with the payer before submitting.
Recorded changes
86,510 on record
Recorded policy changes, newest first| Recorded | Payer | Policy | Change |
|---|
| May 17, 2026 | Capital Blue Cross | Step Therapy Treatment of Stage Four, Advanced Metastatic Cancer and Severe Related Health ConditionsPayerPolicy · CAPBLUE-MP-2.373 | Criteria changed |
|---|
| May 17, 2026 | Capital Blue Cross | Stem Cell Therapy for Peripheral Arterial DiseasePayerPolicy · CAPBLUE-MP-2.089 | Criteria changed |
|---|
| May 17, 2026 | Capital Blue Cross | Spinal Orthoses (other than for Scoliosis)PayerPolicy · CAPBLUE-MP-6.063 | Criteria changed |
|---|
| May 17, 2026 | Capital Blue Cross | Sphenopalatine Ganglion BlockPayerPolicy · CAPBLUE-MP-4.046 | Criteria changed |
|---|
| May 17, 2026 | Capital Blue Cross | Speech Therapy (Outpatient)PayerPolicy · CAPBLUE-MP-8.002 | Criteria changed |
|---|
| May 17, 2026 | Capital Blue Cross | Somatic Genetic Testing to Select Individuals with Melanoma or Glioma for Targeted Therapy or ImmunotherapyPayerPolicy · CAPBLUE-MP-2.364 | Criteria changed |
|---|
| May 17, 2026 | Capital Blue Cross | Somatic Biomarker Testing (Including Liquid Biopsy) for Targeted Treatment of Metastatic Colorectal Cancer (KRAS, NRAS, BRAF, NTRK, and HER2)PayerPolicy · CAPBLUE-MP-2.316 | Criteria changed |
|---|
| May 17, 2026 | Capital Blue Cross | Somatic Biomarker Testing (Including Liquid Biopsy) for Targeted Therapy in Non-Small Cell LungPayerPolicy · CAPBLUE-MP-2.241 | Criteria changed |
|---|
| May 17, 2026 | Capital Blue Cross | Skin Contact Monochromatic Infrared Energy for Treatment of Cutaneous Ulcers, Diabetic Neuropathy and Miscellaneous Musculoskeletal ConditionsPayerPolicy · CAPBLUE-MP-1.094 | Criteria changed |
|---|
| May 17, 2026 | Capital Blue Cross | Serum Biomarkers for Human Epididymis Protein 4 (HE4)PayerPolicy · CAPBLUE-MP-2.269 | Criteria changed |
|---|
| May 17, 2026 | Capital Blue Cross | Serum Antibody Markers for Diagnosing Inflammatory Bowel DiseasePayerPolicy · CAPBLUE-MP-2.222 | Criteria changed |
|---|
| May 17, 2026 | Capital Blue Cross | Sensory Integration Therapy and Auditory Integration TherapyPayerPolicy · CAPBLUE-MP-8.011 | Criteria changed |
|---|
| May 17, 2026 | Capital Blue Cross | Semi-Implantable and Fully Implantable Middle Ear Hearing AidPayerPolicy · CAPBLUE-MP-1.130 | Criteria changed |
|---|
| May 17, 2026 | Capital Blue Cross | Self Administered MedicationsPayerPolicy · CAPBLUE-MP-2.176 | Criteria changed |
|---|
| May 17, 2026 | Capital Blue Cross | Scintimammography and Gamma Imaging of the Breast and AxillaPayerPolicy · CAPBLUE-MP-5.021 | Criteria changed |
|---|
| May 17, 2026 | Capital Blue Cross | Sacral Nerve Neuromodulation-StimulationPayerPolicy · CAPBLUE-MP-1.033 | Criteria changed |
|---|
| May 17, 2026 | Capital Blue Cross | Rhinomanometry and Acoustic/Optical RhinometryPayerPolicy · CAPBLUE-MP-2.088 | Criteria changed |
|---|
| May 17, 2026 | Capital Blue Cross | Responsive Neurostimulation for the Treatment of Refractory Focal EpilepsyPayerPolicy · CAPBLUE-MP-1.156 | Criteria changed |
|---|
| May 17, 2026 | Capital Blue Cross | Renal Denervation for Uncontrolled HypertensionPayerPolicy · CAPBLUE-MP-1.166 | Criteria changed |
|---|
| May 17, 2026 | Capital Blue Cross | Reduction Mammoplasty for Breast-Related SymptomsPayerPolicy · CAPBLUE-MP-1.013 | Criteria changed |
|---|
| May 17, 2026 | Capital Blue Cross | Reconstructive Breast Surgery Including Management of Breast Implants, External Breast Prosthesis and Post Mastectomy BrasPayerPolicy · CAPBLUE-MP-1.103 | Criteria changed |
|---|
| May 17, 2026 | Capital Blue Cross | Recombinant and Autologous Platelet Derived Growth Factors as a Treatment of Wound Healing and Other Non-Orthopedic ConditionsPayerPolicy · CAPBLUE-MP-2.033 | Criteria changed |
|---|
| May 17, 2026 | Capital Blue Cross | Radiofrequency Ablation of Thyroid TumorsPayerPolicy · CAPBLUE-MP-1.165 | Criteria changed |
|---|
| May 17, 2026 | Capital Blue Cross | Radiofrequency Ablation of Primary or Metastatic Liver TumorsPayerPolicy · CAPBLUE-MP-1.055 | Criteria changed |
|---|
| May 17, 2026 | Capital Blue Cross | Radiofrequency Ablation of Miscellaneous Solid Tumors Excluding Liver TumorsPayerPolicy · CAPBLUE-MP-1.084 | Criteria changed |
|---|
| May 17, 2026 | Capital Blue Cross | Proteomic Testing for Targeted Therapy in Non-Small-Cell Lung CancerPayerPolicy · CAPBLUE-MP-2.337 | Criteria changed |
|---|
| May 17, 2026 | Capital Blue Cross | Proteogenomic Testing for Patients With CancerPayerPolicy · CAPBLUE-MP-2.343 | Criteria changed |
|---|
| May 17, 2026 | Capital Blue Cross | Prostatic Urethral LiftPayerPolicy · CAPBLUE-MP-1.147 | Criteria changed |
|---|
| May 17, 2026 | Capital Blue Cross | ProlotherapyPayerPolicy · CAPBLUE-MP-2.061 | Criteria changed |
|---|
| May 17, 2026 | Capital Blue Cross | Preimplantation Genetic TestingPayerPolicy · CAPBLUE-MP-7.009 | Criteria changed |
|---|
| May 17, 2026 | Capital Blue Cross | Power Wheelchairs, Power Operated Vehicles (POV) and Related Options and AccessoriesPayerPolicy · CAPBLUE-MP-6.037 | Criteria changed |
|---|
| May 17, 2026 | Capital Blue Cross | Postsurgical Home Use of Limb Compression Devices for Venous Thromboembolism ProphylaxisPayerPolicy · CAPBLUE-MP-6.053 | Criteria changed |
|---|
| May 17, 2026 | Capital Blue Cross | Polysomnography for Non-Respiratory Sleep DisordersPayerPolicy · CAPBLUE-MP-2.335 | Criteria changed |
|---|
| May 17, 2026 | Capital Blue Cross | Plasma Exchange (PE)PayerPolicy · CAPBLUE-MP-4.031 | Criteria changed |
|---|
| May 17, 2026 | Capital Blue Cross | Placental/Umbilical Cord Blood as Source of Stem CellsPayerPolicy · CAPBLUE-MP-9.001 | Criteria changed |
|---|
| May 17, 2026 | Capital Blue Cross | Photocoagulation Therapy for Treatment of AMDPayerPolicy · CAPBLUE-MP-4.008 | Criteria changed |
|---|
| May 17, 2026 | Capital Blue Cross | Pharmacogenomic and Metabolite Markers for Patients Treated with ThiopurinesPayerPolicy · CAPBLUE-MP-2.218 | Criteria changed |
|---|
| May 17, 2026 | Capital Blue Cross | Periureteral Bulking Agents as Treatment of Vesicoureteral RefluxPayerPolicy · CAPBLUE-MP-1.109 | Criteria changed |
|---|
| May 17, 2026 | Capital Blue Cross | Peripheral Subcutaneous Field Stimulation (PSFS)PayerPolicy · CAPBLUE-MP-1.141 | Criteria changed |
|---|
| May 17, 2026 | Capital Blue Cross | Percutaneous Electrical Nerve Stimulation (PENs) and Percutaneous Neuromodulation Therapy (PNT)PayerPolicy · CAPBLUE-MP-6.050 | Criteria changed |
|---|
| May 17, 2026 | Capital Blue Cross | Percutaneous Electrical Nerve Field Stimulation for Irritable Bowel SyndromePayerPolicy · CAPBLUE-MP-2.397 | Criteria changed |
|---|
| May 17, 2026 | Capital Blue Cross | Pelvic Floor Stimulation as a Treatment of Urinary and Fecal IncontinencePayerPolicy · CAPBLUE-MP-6.024 | Criteria changed |
|---|
| May 17, 2026 | Capital Blue Cross | Paraspinal Surface Electromyography to Evaluate and Monitor Back PainPayerPolicy · CAPBLUE-MP-2.097 | Criteria changed |
|---|
| May 17, 2026 | Capital Blue Cross | Other Therapies of HyperhidrosisPayerPolicy · CAPBLUE-MP-2.005 | Criteria changed |
|---|
| May 17, 2026 | Capital Blue Cross | Orthopedic Applications of Stem Cell Therapy (Including Allograft and Bone Substitute Products Used with Autologous Bone Marrow)PayerPolicy · CAPBLUE-MP-2.080 | Criteria changed |
|---|
| May 17, 2026 | Capital Blue Cross | Orthopedic Applications of Platelet Rich PlasmaPayerPolicy · CAPBLUE-MP-4.039 | Criteria changed |
|---|
| May 17, 2026 | Capital Blue Cross | Optical Coherence Tomography (OCT) of the Anterior Eye SegmentPayerPolicy · CAPBLUE-MP-2.085 | Criteria changed |
|---|
| May 17, 2026 | Capital Blue Cross | Ophthalmologic Techniques That Evaluate the Posterior Eye SegmentPayerPolicy · CAPBLUE-MP-2.056 | Criteria changed |
|---|
| May 17, 2026 | Capital Blue Cross | Open and Thoracoscopic Approaches to Treat Atrial Fibrillation and Atrial Flutter (Maze and Related Procedures)PayerPolicy · CAPBLUE-MP-2.083 | Criteria changed |
|---|
| May 17, 2026 | Capital Blue Cross | Oncological Applications of Photodynamic Therapy including Barrett's EsophagusPayerPolicy · CAPBLUE-MP-4.019 | Criteria changed |
|---|